Nurtec is the first drug approved for acute and preventive treatment of migraines.
Nurtec is the first drug approved for acute and preventive treatment of migraines.
Biohaven, the manufacturer of rimegepant (Nurtec ODT) just received FDA approval to market this drug for the prevention of migraines. Rimegepant was approved in January of 2020 for the acute treatment of migraine headaches. It is the first drug to be approved for both acute and preventive therapy of migraines. Rimegepant is one of six drugs that block the action of calcitonin gene-related peptide…
View On WordPress


















